|
?:authorAffiliation
|
-
[\'Cancer Immunology Program, Peter MacCallum Cancer Centre, Melbourne, Australia. Mohamed.fareh@petermac.org.\', \'Sir Peter MacCallum Department of Oncology, The University of Melbourne, Parkville, Australia. Mohamed.fareh@petermac.org.\', \'The Department of Infectious Diseases, The University of Melbourne at the Peter Doherty Institute for Infection and Immunity, Melbourne, Australia.\', \'Cancer Immunology Program, Peter MacCallum Cancer Centre, Melbourne, Australia.\', \'Sir Peter MacCallum Department of Oncology, The University of Melbourne, Parkville, Australia.\', \'Murdoch Children\'s Research Institute, Parkville, Australia.\', \'Children\'s Cancer Institute, Randwick, NSW, Australia.\', \'WHO Collaborating Centre for Research and Reference in Influenza, Royal Melbourne Hospital at the Peter Doherty Institute for Infection and Immunity, Melbourne, Australia.\', \'Department of Microbiology and Immunology, The University of Melbourne at the Peter Doherty Institute for Infection and Immunity, Melbourne, Australia.\', \'The Department of Infectious Diseases, The University of Melbourne at the Peter Doherty Institute for Infection and Immunity, Melbourne, Australia. sharon.lewin@unimelb.edu.au.\', \'Victorian Infectious Diseases Service, Royal Melbourne Hospital at the Peter Doherty Institute for Infection and Immunity, Melbourne, Australia. sharon.lewin@unimelb.edu.au.\', \'Department of Infectious Diseases, Alfred Hospital and Monash University, Melbourne, Australia. sharon.lewin@unimelb.edu.au.\']
|
![[This page as RDF]](https://research.tib.eu/covid-19/static/rdf-icon.gif){kind=icon}